STUART NATHAN: Open Payments
NPI 1407836869 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,375 in 125 payments from 21 companies in 2025. Trend: 2023 $1,760 · 2024 $1,784 · 2025 $2,375
Food & beverage: $2,375
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $640 |
| ABBVIE INC. | 8 | $278 |
| Lilly USA, LLC | 22 | $271 |
| AstraZeneca Pharmaceuticals LP | 8 | $211 |
| GlaxoSmithKline, LLC. | 18 | $172 |
| PFIZER INC. | 10 | $150 |
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Lundbeck LLC | 4 | $93 |
| Amgen Inc. | 4 | $64 |
| Exact Sciences Corporation | 3 | $55 |
Products named: Ozempic, REXULTI, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, Rybelsus, FARXIGA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
